Illinois-based niche pharmaceutical firm Akorn Inc acquired the US rights to three branded ophthalmic products from New Jersey-based international pharmaceutical company Merck for USD52.8 million.
Medical
Weigao Group to sell entire stake in Biosensors
China's Shandong Weigao Group Medical Polymer Co Ltd announced its intention to sell its entire 21.7% stake in medical device manufacturer Biosensors International Group Ltd for USD312.3 million.
Top deals of the day - bids, mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported on Thursday including Omnicom, General Motors, Deutsche Telekom, Devon Energy and others
Johnson & Johnson selects two bidders for diagnostics unit sale
Sources name the Carlyle Group LP and a combined group from Danaher Corp and Blackstone Group LP to have successfully advanced to the final stage of sale negotiations for J&J's diagnostics unit
iSTAR Medical Raises EUR 4 million in Series A Financing
iSTAR Medical SA, a privately held ophthalmic device company and first spinout of Healionics Corporation, today announced it has raised EUR 4.0 million from institutional investors in a Series A financing.
Latest News
The following bids, mergers, acquisitions and disposals were reported on Wednesday including BNP Paribas, Facebook, Crocs, VTB Capital and Flybe Group.
Rakuten Inc sought court action to stop the passage of the bill to prohibit the over the counter sales of certain drugs over the Internet.
Biotechnology company Hologic Inc. announced a repurchase program for its common stocks worth USD250 million. Under said program, it will be allowed to buy back shares of its stocks in open markets and privately negotiated transactions.
Merz Pharma group recently bought Geneva-based aesthetics medicine specialist Antes SA for an unconfirmed amount in a transaction that would extend its product reach to North America
The USD4.2 billion purchase by Shire Plc of ViroPharma Inc is the highest purchase on EBITDA rates for a biotechnology firm in history, as the price is 58 times EBITDA.
Assam Chief Minister Tarun Gogoi, in a press conference, discussed the construction of a cancer and surgical cleft center in his state with the help of private entities.
Symbion, which was privatized in 2007, is preparing for its sale. Surgical facilities operator Symbion Inc, which was privatized back in 2007, is now up for sale.
Many private equity firms and partnerships are in the process of formulating their bids for diagnostic unit of Johnson&Johnson.
An announcement made last Thursday of a realignment in priority drug research projects prompted Citi analyst to advise shareholders of a possible interest divestment in diabetes drug joint venture between Bristol-Myers Squibb and AstraZeneca.
